Ụlọ ọrụ ngwaahịa | Ndị na-emepụta ngwaahịa China, ndị na-eweta ngwaahịa

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Dabrafenib

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Dabrafenib

ajuju nkọwa
Aprocitentan

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Aprocitentan

ajuju nkọwa
Etrasimod

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Etrasimod Ulceratuve colitis (UC) Arena (Pfizer) Maachị 05,2030

ajuju nkọwa
Tirzepatide

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Tirzepatide Ụdị ọrịa shuga 2, felata Eli Lilly Ọnwa Mbụ 05,2036

ajuju nkọwa
Semaglutide

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Semaglutide Ụdị ọrịa shuga 2, felata Novo Nordisk Dec.05,2031

ajuju nkọwa

Oteseconazole — Oteseconazole

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Oteseconazole Belata ọnụego ihe omume nke

vulvovaginal candidiasis ugboro ugboro
Mycovia Pharmaceuticals Eprel 22,2031

ajuju nkọwa

Finerenone

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Finerenone Ọrịa mamịrị nephropathy Bayer Eprel 12,2029

ajuju nkọwa
Vibegron

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Vibegron OAB Urovant Dec.01,2030

ajuju nkọwa
Capivasertib

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Capivasertib ọrịa ara ara AstraZeneca Maachị 10.2030

ajuju nkọwa
Resmetirom

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Resmetirom NASH Roche Septemba 12,2026

ajuju nkọwa
Darolutamide

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Darolutamide ọgwụgwọ ọrịa cancer prostate Bayer Ọnwa Atọ 25,2033

ajuju nkọwa
Upadacitinib

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)

Upadacitinib Atopic dermatitis Ụlọ ọrụ ABBVIE INC Dec.01,2030

ajuju nkọwa

1 2 3 4 5 6 Ọzọ >>> Peeji nke 1/6